Independent Director Bakul Dholakia Retired from the Board of Arvind
The second term of Dr. Bakul Dholakia as an Independent Director of Arvind Limited is expiring on July 31, 2024.
Solara Active Pharma Sciences’ Ankur Thadani Resigns as Non-Executive Independent Director
Ankur Thadani, Non-Executive Non-Independent Director of Solara Active Pharma Sciences Limited, has resigned from the Board due to preoccupations.
KEI Industries Appoints Vinay Mittal as Independent Director
The Board of Directors of KEI Industries Limited has approved the appointment of Vinay Mittal as an Additional Non-Executive Independent Director for five years w.e.f. July 29, 2024.
Navin Fluorine International’s Independent Director Radhika Haribhakti Retires
Radhika Haribhakti shall cease to be an Independent Director of Navin Fluorine International Limited upon completion of her second term on July 29, 2024.
Insider-Trading Regulations: SEBI Proposes Extending The List Of Connected Persons
The Securities and Exchange Board of India (SEBI), the market regulator, has suggested broadening the definition of "connected persons" under the SEBI (Prohibition of Insider Trading) Regulations (PIT Regulations) to include more relatives.
The Average Cost Of Data Breaches In India Is $2.18 Million: RBI Report
According to the Reserve Bank of India's (RBI) Currency and Finance report for 2023–24, the average cost of data breaches in India rose to $2.18 million in 2023, marking a 28% increase since the year 2020.
Tech Mahindra Appoints Tarun Bajaj & Neelam Dhawan as Independent Directors
The shareholders of Tech Mahindra Limited have approved the appointment of Tarun Bajaj and Neelam Dhawan as Independent Directors for five years, with effect from July 26, 2024.
Nykaa’s Falguni Nayar Retired from Dabur India’s Board
Falguni Sanjay Nayar, Non-Executive Independent Director of Dabur India Limited, has completed her second term on July 27, 2024, and consequently has ceased as Director of the Company w.e.f. July 28, 2024.
Independent Director Kalpana Morparia retires from Dr. Reddy’s Board
Kalpana Morparia will cease to be an Independent Director (Lead Independent Director) of Dr. Reddy's Laboratories Limited with effect from July 30, 2024, after completion of her second term of directorship.
Cholamandalam Investment elevates Executive Director Ravindra Kundu to MD
Ravindra Kumar Kundu, currently serving as the Executive Director of Cholamandalam Investment and Finance Company Limited, has been appointed as its new Managing Director (MD) for a term of five years, with effect from October 7, 2024.
